Autism Spectrum Disorder and School Bullying: Who is the Victim? Who is the Perpetrator? / S. HWANG in Journal of Autism and Developmental Disorders, 48-1 (January 2018)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 48-1 (January 2018) . - p.225-238 Titre : Autism Spectrum Disorder and School Bullying: Who is the Victim? Who is the Perpetrator? Type de document : Texte imprimé et/ou numérique Auteurs : S. HWANG, Auteur ; Y. S. KIM, Auteur ; Y. J. KOH, Auteur ; Bennett L. LEVENTHAL, Auteur Article en page(s) : p.225-238 Langues : Anglais (eng) Mots-clés : Autism diagnostic observation scale and autism diagnostic interview  Autism spectrum disorder  Behavior assessment system for children  Comorbid psychopathology  Dsm-5  School bullying Index. décimale : PER Périodiques Résumé : While a growing number of studies indicate associations between experiences of bullying and autism spectrum disorder (ASD), it is not clear what roles comorbid behavioral problems may play. We investigated the experiences of children with ASD as victims and/or perpetrators of bullying. Children with ASD epidemiologically ascertained participated in a cross-sectional study. Although children with ASD showed significantly increased risk for bullying involvement compared to community children, after controlling for comorbid psychopathology and other demographic factors, increased risks for being perpetrators or victim-perpetrators disappeared while risk for being bullied/teased continued to be significantly elevated. This finding will help guide medical, educational and community personnel to effectively identify children with ASD at risk for school bullying and develop interventions. En ligne : https://doi.org/10.1007/s10803-017-3285-z Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=337 [article] Autism Spectrum Disorder and School Bullying: Who is the Victim? Who is the Perpetrator? [Texte imprimé et/ou numérique] / S. HWANG, Auteur ; Y. S. KIM, Auteur ; Y. J. KOH, Auteur ; Bennett L. LEVENTHAL, Auteur . - p.225-238. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 48-1 (January 2018) . - p.225-238 Mots-clés : Autism diagnostic observation scale and autism diagnostic interview  Autism spectrum disorder  Behavior assessment system for children  Comorbid psychopathology  Dsm-5  School bullying Index. décimale : PER Périodiques Résumé : While a growing number of studies indicate associations between experiences of bullying and autism spectrum disorder (ASD), it is not clear what roles comorbid behavioral problems may play. We investigated the experiences of children with ASD as victims and/or perpetrators of bullying. Children with ASD epidemiologically ascertained participated in a cross-sectional study. Although children with ASD showed significantly increased risk for bullying involvement compared to community children, after controlling for comorbid psychopathology and other demographic factors, increased risks for being perpetrators or victim-perpetrators disappeared while risk for being bullied/teased continued to be significantly elevated. This finding will help guide medical, educational and community personnel to effectively identify children with ASD at risk for school bullying and develop interventions. En ligne : https://doi.org/10.1007/s10803-017-3285-z Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=337

Automated recognition of spontaneous facial expression in individuals with autism spectrum disorder: parsing response variability / Abigail BANGERTER in Molecular Autism, 11 (2020)  

Public ISBD [article]  inMolecular Autism > 11 (2020) . - 31 p. Titre : Automated recognition of spontaneous facial expression in individuals with autism spectrum disorder: parsing response variability Type de document : Texte imprimé et/ou numérique Auteurs : Abigail BANGERTER, Auteur ; Meenakshi CHATTERJEE, Auteur ; Joseph MANFREDONIA, Auteur ; Nikolay V. MANYAKOV, Auteur ; Seth NESS, Auteur ; Matthew A. BOICE, Auteur ; Andrew SKALKIN, Auteur ; Matthew S GOODWIN, Auteur ; Geraldine DAWSON, Auteur ; Robert HENDREN, Auteur ; Bennett L. LEVENTHAL, Auteur ; Frederick SHIC, Auteur ; Gahan PANDINA, Auteur Article en page(s) : 31 p. Langues : Anglais (eng) Mots-clés : Autism spectrum disorder  Emotional regulation  Emotions  Facial expression  Impulsive behavior  LLC, and may hold company equity. AS was an employee of Janssen Research &  Development at the time of the study. MSG has received research and consulting  funding from Janssen Research & Development. GD is on the Scientific Advisory Boards  of Janssen Research & Development  Akili, Inc.  LabCorp, Inc.  and Roche  Pharmaceutical Company  is a consultant for Apple, Inc  Gerson Lehrman Group  Guidepoint, Inc.  and Axial Ventures  has received grant funding from Janssen  Research & Development  and is the CEO of DASIO, LLC. GD receives royalties from  Guilford Press, Springer, and Oxford University Press. RH received reimbursement for  consultation from Janssen Research & Development. BL has received research grant  funding from the NIH  is a consultant to Janssen Research & Development, the  Illinois Children’s Healthcare Foundation  and is a board member of the Brain  Research Foundation. FS is on the Scientific Advisory Board, is a consultant to and  received grant funding from Janssen Research & Development, and has also received  grant funding from Roche. Index. décimale : PER Périodiques Résumé : BACKGROUND: Reduction or differences in facial expression are a core diagnostic feature of autism spectrum disorder (ASD), yet evidence regarding the extent of this discrepancy is limited and inconsistent. Use of automated facial expression detection technology enables accurate and efficient tracking of facial expressions that has potential to identify individual response differences. METHODS: Children and adults with ASD (N = 124) and typically developing (TD, N = 41) were shown short clips of "funny videos." Using automated facial analysis software, we investigated differences between ASD and TD groups and within the ASD group in evidence of facial action unit (AU) activation related to the expression of positive facial expression, in particular, a smile. RESULTS: Individuals with ASD on average showed less evidence of facial AUs (AU12, AU6) relating to positive facial expression, compared to the TD group (p < .05, r = -?0.17). Using Gaussian mixture model for clustering, we identified two distinct distributions within the ASD group, which were then compared to the TD group. One subgroup (n = 35), termed "over-responsive," expressed more intense positive facial expressions in response to the videos than the TD group (p < .001, r = 0.31). The second subgroup (n = 89), ("under-responsive"), displayed fewer, less intense positive facial expressions in response to videos than the TD group (p < .001; r = -?0.36). The over-responsive subgroup differed from the under-responsive subgroup in age and caregiver-reported impulsivity (p < .05, r = 0.21). Reduced expression in the under-responsive, but not the over-responsive group, was related to caregiver-reported social withdrawal (p < .01, r = -?0.3). LIMITATIONS: This exploratory study does not account for multiple comparisons, and future work will have to ascertain the strength and reproducibility of all results. Reduced displays of positive facial expressions do not mean individuals with ASD do not experience positive emotions. CONCLUSIONS: Individuals with ASD differed from the TD group in their facial expressions of positive emotion in response to "funny videos." Identification of subgroups based on response may help in parsing heterogeneity in ASD and enable targeting of treatment based on subtypes. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02299700. Registration date: November 24, 2014. En ligne : http://dx.doi.org/10.1186/s13229-020-00327-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=427 [article] Automated recognition of spontaneous facial expression in individuals with autism spectrum disorder: parsing response variability [Texte imprimé et/ou numérique] / Abigail BANGERTER, Auteur ; Meenakshi CHATTERJEE, Auteur ; Joseph MANFREDONIA, Auteur ; Nikolay V. MANYAKOV, Auteur ; Seth NESS, Auteur ; Matthew A. BOICE, Auteur ; Andrew SKALKIN, Auteur ; Matthew S GOODWIN, Auteur ; Geraldine DAWSON, Auteur ; Robert HENDREN, Auteur ; Bennett L. LEVENTHAL, Auteur ; Frederick SHIC, Auteur ; Gahan PANDINA, Auteur . - 31 p. Langues : Anglais (eng) in Molecular Autism > 11 (2020) . - 31 p. Mots-clés : Autism spectrum disorder  Emotional regulation  Emotions  Facial expression  Impulsive behavior  LLC, and may hold company equity. AS was an employee of Janssen Research &  Development at the time of the study. MSG has received research and consulting  funding from Janssen Research & Development. GD is on the Scientific Advisory Boards  of Janssen Research & Development  Akili, Inc.  LabCorp, Inc.  and Roche  Pharmaceutical Company  is a consultant for Apple, Inc  Gerson Lehrman Group  Guidepoint, Inc.  and Axial Ventures  has received grant funding from Janssen  Research & Development  and is the CEO of DASIO, LLC. GD receives royalties from  Guilford Press, Springer, and Oxford University Press. RH received reimbursement for  consultation from Janssen Research & Development. BL has received research grant  funding from the NIH  is a consultant to Janssen Research & Development, the  Illinois Children’s Healthcare Foundation  and is a board member of the Brain  Research Foundation. FS is on the Scientific Advisory Board, is a consultant to and  received grant funding from Janssen Research & Development, and has also received  grant funding from Roche. Index. décimale : PER Périodiques Résumé : BACKGROUND: Reduction or differences in facial expression are a core diagnostic feature of autism spectrum disorder (ASD), yet evidence regarding the extent of this discrepancy is limited and inconsistent. Use of automated facial expression detection technology enables accurate and efficient tracking of facial expressions that has potential to identify individual response differences. METHODS: Children and adults with ASD (N = 124) and typically developing (TD, N = 41) were shown short clips of "funny videos." Using automated facial analysis software, we investigated differences between ASD and TD groups and within the ASD group in evidence of facial action unit (AU) activation related to the expression of positive facial expression, in particular, a smile. RESULTS: Individuals with ASD on average showed less evidence of facial AUs (AU12, AU6) relating to positive facial expression, compared to the TD group (p < .05, r = -?0.17). Using Gaussian mixture model for clustering, we identified two distinct distributions within the ASD group, which were then compared to the TD group. One subgroup (n = 35), termed "over-responsive," expressed more intense positive facial expressions in response to the videos than the TD group (p < .001, r = 0.31). The second subgroup (n = 89), ("under-responsive"), displayed fewer, less intense positive facial expressions in response to videos than the TD group (p < .001; r = -?0.36). The over-responsive subgroup differed from the under-responsive subgroup in age and caregiver-reported impulsivity (p < .05, r = 0.21). Reduced expression in the under-responsive, but not the over-responsive group, was related to caregiver-reported social withdrawal (p < .01, r = -?0.3). LIMITATIONS: This exploratory study does not account for multiple comparisons, and future work will have to ascertain the strength and reproducibility of all results. Reduced displays of positive facial expressions do not mean individuals with ASD do not experience positive emotions. CONCLUSIONS: Individuals with ASD differed from the TD group in their facial expressions of positive emotion in response to "funny videos." Identification of subgroups based on response may help in parsing heterogeneity in ASD and enable targeting of treatment based on subtypes. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02299700. Registration date: November 24, 2014. En ligne : http://dx.doi.org/10.1186/s13229-020-00327-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=427

Between a ROC and a hard place: decision making and making decisions about using the SCQ / Christina M. CORSELLO in Journal of Child Psychology and Psychiatry, 48-9 (September 2007)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 48-9 (September 2007) . - p.932–940 Titre : Between a ROC and a hard place: decision making and making decisions about using the SCQ Type de document : Texte imprimé et/ou numérique Auteurs : Christina M. CORSELLO, Auteur ; Catherine LORD, Auteur ; Andrew PICKLES, Auteur ; Susan RISI, Auteur ; Vanessa HUS, Auteur ; Edwin H. Jr COOK, Auteur ; Bennett L. LEVENTHAL, Auteur Année de publication : 2007 Article en page(s) : p.932–940 Langues : Anglais (eng) Mots-clés : Autistic-disorder diagnosis screening Social-Communication-Questionnaire Index. décimale : PER Périodiques Résumé : Background: The Social Communication Questionnaire (SCQ), formerly the Autism Screening Questionnaire (ASQ), is based on a well-validated parent interview, the Autism Diagnostic Interview (ADI). It has shown promise as a screening measure for autism spectrum disorders (ASDs) in a research-referred older sample, though recent studies with younger children reported lower sensitivities when using the suggested cutoff of ≥15 to differentiate ASDs from children with nonspectrum disorders (NS). Methods: Diagnostic discrimination of the SCQ was evaluated alone and in combination with the ADOS (Autism Diagnostic Observation Schedule) in a clinical and research-referred sample of 590 children and adolescents (2 to 16 years), with best estimate consensus diagnoses of autism, pervasive developmental disorder, not otherwise specified (PDD-NOS) and non-ASD disorders. The SCQ was completed before the evaluation in most cases. Performance of the SCQ was also compared with the Autism Diagnostic Interview – Revised (ADI-R). Results: Absolute scores and sensitivity in the younger children and specificity for all groups were lower than reported in the original study. Using receiver operating curves (ROC) to examine the area under the curve (AUC), the SCQ was more similar to the ADI-R total score in differentiating ASD from NS disorders in the older (8–10, >11) than younger age groups (<5, 5–7). Lowering the cutoff score in the 2 younger groups improved sensitivity, with specificity remaining relatively low in all groups. Using the SCQ in combination with the ADOS resulted in improved specificity. Diagnostic discrimination was best using the ADI-R and ADOS in combination. Conclusions: Those interested in using the SCQ should consider adjusting cutoff scores according to age and purpose, and using it in combination with another measure. Sensitivity or specificity may be prioritized for research or screening depending on goals. En ligne : http://dx.doi.org/10.1111/j.1469-7610.2007.01762.x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=164 [article] Between a ROC and a hard place: decision making and making decisions about using the SCQ [Texte imprimé et/ou numérique] / Christina M. CORSELLO, Auteur ; Catherine LORD, Auteur ; Andrew PICKLES, Auteur ; Susan RISI, Auteur ; Vanessa HUS, Auteur ; Edwin H. Jr COOK, Auteur ; Bennett L. LEVENTHAL, Auteur . - 2007 . - p.932–940. Langues : Anglais (eng) in Journal of Child Psychology and Psychiatry > 48-9 (September 2007) . - p.932–940 Mots-clés : Autistic-disorder diagnosis screening Social-Communication-Questionnaire Index. décimale : PER Périodiques Résumé : Background: The Social Communication Questionnaire (SCQ), formerly the Autism Screening Questionnaire (ASQ), is based on a well-validated parent interview, the Autism Diagnostic Interview (ADI). It has shown promise as a screening measure for autism spectrum disorders (ASDs) in a research-referred older sample, though recent studies with younger children reported lower sensitivities when using the suggested cutoff of ≥15 to differentiate ASDs from children with nonspectrum disorders (NS). Methods: Diagnostic discrimination of the SCQ was evaluated alone and in combination with the ADOS (Autism Diagnostic Observation Schedule) in a clinical and research-referred sample of 590 children and adolescents (2 to 16 years), with best estimate consensus diagnoses of autism, pervasive developmental disorder, not otherwise specified (PDD-NOS) and non-ASD disorders. The SCQ was completed before the evaluation in most cases. Performance of the SCQ was also compared with the Autism Diagnostic Interview – Revised (ADI-R). Results: Absolute scores and sensitivity in the younger children and specificity for all groups were lower than reported in the original study. Using receiver operating curves (ROC) to examine the area under the curve (AUC), the SCQ was more similar to the ADI-R total score in differentiating ASD from NS disorders in the older (8–10, >11) than younger age groups (<5, 5–7). Lowering the cutoff score in the 2 younger groups improved sensitivity, with specificity remaining relatively low in all groups. Using the SCQ in combination with the ADOS resulted in improved specificity. Diagnostic discrimination was best using the ADI-R and ADOS in combination. Conclusions: Those interested in using the SCQ should consider adjusting cutoff scores according to age and purpose, and using it in combination with another measure. Sensitivity or specificity may be prioritized for research or screening depending on goals. En ligne : http://dx.doi.org/10.1111/j.1469-7610.2007.01762.x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=164

Childhood vaccination as a protective factor for developmental psychopathology / Bora KIM in Research in Autism Spectrum Disorders, 79 (November 2020)  

Public ISBD [article]  inResearch in Autism Spectrum Disorders > 79 (November 2020) . - 101653 Titre : Childhood vaccination as a protective factor for developmental psychopathology Type de document : Texte imprimé et/ou numérique Auteurs : Bora KIM, Auteur ; Mina HA, Auteur ; Young Shin KIM, Auteur ; Yun-Joo KOH, Auteur ; Ho-Jang KWON, Auteur ; Myung-Ho LIM, Auteur ; Ki-Chung PAIK, Auteur ; Hosanna KIM, Auteur ; Patricia HONG, Auteur ; Bennett L. LEVENTHAL, Auteur Article en page(s) : 101653 Langues : Anglais (eng) Mots-clés : ASD  Developmental psychopathology  Vaccination  Protective effects Index. décimale : PER Périodiques Résumé : Backgrounds Despite multiple studies demonstrating no relationship between childhood vaccination and increasing Autism Spectrum Disorder (ASD) prevalence, parental fear for vaccination and subsequent refusal to vaccinate their children continue, resulting in recent outbreaks of childhood infections such as measles in the US. We examine the relationship between the completion of 6 recommended vaccinations in childhood and the likelihood for having developmental psychopathology. Methods Two large-scale South Korean epidemiologic samples were used to examine whether completion of childhood vaccinations decrease likelihood of having ASD as assessed by Autism Spectrum Screening Questionnaire (ASSQ) and behavioral problems scores. Parental reports on vaccination completion were categorized in groups: <3, 4?5, & 6. The primary outcome is the likelihood of having ASD and/or, internalizing, and externalizing behavioral symptoms. Likelihood of having ASD was categorized as: low (ASSQ < 10), intermediate (ASSQ = 10–14), and high (ASSQ ? 15). The risk for externalizing/internalizing symptoms was assessed with the Behavior Assessment System for Children-Parent Rating Scale. We examined the hypothesis in a Discovery Sample (DS) (N = 10,006) and verified findings in a Replication Sample (RS) (N = 29,381). Results 84.3 % of DS and 80.1 % of RS participants were fully vaccinated. In the DS, after adjusting for demographics and confounders, children with incomplete-vaccinations were at greater risk for ASD when compared to those fully vaccinated (adjusted odds ratio [aOR] = 1.42, 95 % Confidence Interval [CI] 1.17?1.73 with 4?5 vaccinations; aOR = 2.33, CI 1.53?3.56 with vaccination <3). The DS finding was confirmed in the RS (aOR = 1.44, CI 1.32?1.58 with 4?5 vaccinations and aOR = 2.19, CI 1.80?2.67 with < 3 vaccinations). In the DS, those with incomplete-vaccinations were at a greater risk for internalizing and externalizing symptoms. Conclusions We replicate our own and prior findings that vaccination does not increase ASD risk. Further, completing recommended vaccinations may offer protection against the risk of having ASD and other developmental psychopathology. En ligne : https://doi.org/10.1016/j.rasd.2020.101653 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=434 [article] Childhood vaccination as a protective factor for developmental psychopathology [Texte imprimé et/ou numérique] / Bora KIM, Auteur ; Mina HA, Auteur ; Young Shin KIM, Auteur ; Yun-Joo KOH, Auteur ; Ho-Jang KWON, Auteur ; Myung-Ho LIM, Auteur ; Ki-Chung PAIK, Auteur ; Hosanna KIM, Auteur ; Patricia HONG, Auteur ; Bennett L. LEVENTHAL, Auteur . - 101653. Langues : Anglais (eng) in Research in Autism Spectrum Disorders > 79 (November 2020) . - 101653 Mots-clés : ASD  Developmental psychopathology  Vaccination  Protective effects Index. décimale : PER Périodiques Résumé : Backgrounds Despite multiple studies demonstrating no relationship between childhood vaccination and increasing Autism Spectrum Disorder (ASD) prevalence, parental fear for vaccination and subsequent refusal to vaccinate their children continue, resulting in recent outbreaks of childhood infections such as measles in the US. We examine the relationship between the completion of 6 recommended vaccinations in childhood and the likelihood for having developmental psychopathology. Methods Two large-scale South Korean epidemiologic samples were used to examine whether completion of childhood vaccinations decrease likelihood of having ASD as assessed by Autism Spectrum Screening Questionnaire (ASSQ) and behavioral problems scores. Parental reports on vaccination completion were categorized in groups: <3, 4?5, & 6. The primary outcome is the likelihood of having ASD and/or, internalizing, and externalizing behavioral symptoms. Likelihood of having ASD was categorized as: low (ASSQ < 10), intermediate (ASSQ = 10–14), and high (ASSQ ? 15). The risk for externalizing/internalizing symptoms was assessed with the Behavior Assessment System for Children-Parent Rating Scale. We examined the hypothesis in a Discovery Sample (DS) (N = 10,006) and verified findings in a Replication Sample (RS) (N = 29,381). Results 84.3 % of DS and 80.1 % of RS participants were fully vaccinated. In the DS, after adjusting for demographics and confounders, children with incomplete-vaccinations were at greater risk for ASD when compared to those fully vaccinated (adjusted odds ratio [aOR] = 1.42, 95 % Confidence Interval [CI] 1.17?1.73 with 4?5 vaccinations; aOR = 2.33, CI 1.53?3.56 with vaccination <3). The DS finding was confirmed in the RS (aOR = 1.44, CI 1.32?1.58 with 4?5 vaccinations and aOR = 2.19, CI 1.80?2.67 with < 3 vaccinations). In the DS, those with incomplete-vaccinations were at a greater risk for internalizing and externalizing symptoms. Conclusions We replicate our own and prior findings that vaccination does not increase ASD risk. Further, completing recommended vaccinations may offer protection against the risk of having ASD and other developmental psychopathology. En ligne : https://doi.org/10.1016/j.rasd.2020.101653 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=434

Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder / Abigail BANGERTER in Journal of Autism and Developmental Disorders, 50-6 (June 2020)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 50-6 (June 2020) . - p.2090-2101 Titre : Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder Type de document : Texte imprimé et/ou numérique Auteurs : Abigail BANGERTER, Auteur ; Seth NESS, Auteur ; David LEWIN, Auteur ; Michael G. AMAN, Auteur ; Anna J. ESBENSEN, Auteur ; Matthew S GOODWIN, Auteur ; Geraldine DAWSON, Auteur ; Robert HENDREN, Auteur ; Bennett L. LEVENTHAL, Auteur ; Fred SHIC, Auteur ; Mark OPLER, Auteur ; Kai Fai HO, Auteur ; Gahan PANDINA, Auteur Article en page(s) : p.2090-2101 Langues : Anglais (eng) Mots-clés : Assessment  Autism spectrum disorder  Caregiver-reported outcomes  Clinical trials  Rating scales and instruments  hold company stocks/stock options. Anna Esbensen has consulted with Roche on outcome  measures in Down syndrome and ProPhase LLC. Robert Hendren received reimbursement  for consultation from Janssen Research & Development, LLC. Michael Aman has received  research contracts, consulted with, served on advisory boards, or done investigator  training for AMO Pharma, Bracket, CogState, Inc., CogState Clinical Trials, Ltd.,  Coronado Biosciences, Forest Research, Hoffman-La Roche, Lumos Pharma, MedAvante,  Inc., Ovid Therapeutics  ProPhase LLC, Supernus Pharmaceuticals, Zynerba  Pharmaceuticals, and Yamo Pharmaceuticals. He receives royalties from Slosson  Educational Publications. Geraldine Dawson is on the Scientific Advisory Boards of  Janssen Research and Development, LabCorp, and Akili, Inc., a consultant to Roche  has received grant funding from Janssen Research and Development, LLC and  PerkinElmer  and, receives royalties from Guilford Press and Oxford University  Press. Index. décimale : PER Périodiques Résumé : There is a need for measures to track symptom change in autism spectrum disorder (ASD). We conducted a validation study on a revised version of the Autism Behavior Inventory (ABI), and a short form (ABI-S). Caregivers of individuals (6-54 years) with confirmed diagnoses of ASD (N?=?144) completed the ABI and other rating scales at 4 time points. Scale consistency for each domain, 3-5 day test-retest reliability, and construct validity, determined by comparison to pre-specified scales, were all good. Change in the ABI was congruent with changes in other instruments. Collectively, results suggest incipient suitability of the ABI as a measure of changes in core and associated symptoms of ASD.Trial Registration NCT02299700. En ligne : http://dx.doi.org/10.1007/s10803-019-03965-7 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=425 [article] Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder [Texte imprimé et/ou numérique] / Abigail BANGERTER, Auteur ; Seth NESS, Auteur ; David LEWIN, Auteur ; Michael G. AMAN, Auteur ; Anna J. ESBENSEN, Auteur ; Matthew S GOODWIN, Auteur ; Geraldine DAWSON, Auteur ; Robert HENDREN, Auteur ; Bennett L. LEVENTHAL, Auteur ; Fred SHIC, Auteur ; Mark OPLER, Auteur ; Kai Fai HO, Auteur ; Gahan PANDINA, Auteur . - p.2090-2101. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 50-6 (June 2020) . - p.2090-2101 Mots-clés : Assessment  Autism spectrum disorder  Caregiver-reported outcomes  Clinical trials  Rating scales and instruments  hold company stocks/stock options. Anna Esbensen has consulted with Roche on outcome  measures in Down syndrome and ProPhase LLC. Robert Hendren received reimbursement  for consultation from Janssen Research & Development, LLC. Michael Aman has received  research contracts, consulted with, served on advisory boards, or done investigator  training for AMO Pharma, Bracket, CogState, Inc., CogState Clinical Trials, Ltd.,  Coronado Biosciences, Forest Research, Hoffman-La Roche, Lumos Pharma, MedAvante,  Inc., Ovid Therapeutics  ProPhase LLC, Supernus Pharmaceuticals, Zynerba  Pharmaceuticals, and Yamo Pharmaceuticals. He receives royalties from Slosson  Educational Publications. Geraldine Dawson is on the Scientific Advisory Boards of  Janssen Research and Development, LabCorp, and Akili, Inc., a consultant to Roche  has received grant funding from Janssen Research and Development, LLC and  PerkinElmer  and, receives royalties from Guilford Press and Oxford University  Press. Index. décimale : PER Périodiques Résumé : There is a need for measures to track symptom change in autism spectrum disorder (ASD). We conducted a validation study on a revised version of the Autism Behavior Inventory (ABI), and a short form (ABI-S). Caregivers of individuals (6-54 years) with confirmed diagnoses of ASD (N?=?144) completed the ABI and other rating scales at 4 time points. Scale consistency for each domain, 3-5 day test-retest reliability, and construct validity, determined by comparison to pre-specified scales, were all good. Change in the ABI was congruent with changes in other instruments. Collectively, results suggest incipient suitability of the ABI as a measure of changes in core and associated symptoms of ASD.Trial Registration NCT02299700. En ligne : http://dx.doi.org/10.1007/s10803-019-03965-7 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=425

A contrast of comorbid condition and adaptive function between children with Autism Spectrum Disorder from clinical and non-clinical populations / Ju Hee PARK in Research in Autism Spectrum Disorders, 8-11 (November 2014)  

Permalink

A developmental framework for distinguishing disruptive behavior from normative misbehavior in preschool children / Lauren S. WAKSCHLAG in Journal of Child Psychology and Psychiatry, 48-10 (October 2007)  

Permalink

Differences in the severity and variability of restricted and repetitive behaviors in ASD children with and without service experiences / Ju Hee PARK in Research in Autism Spectrum Disorders, 79 (November 2020)  

Permalink

Editorial: A global perspective on child and adolescent mental health / James F. LECKMAN in Journal of Child Psychology and Psychiatry, 49-3 (March 2008)  

Permalink

Family-based association testing of OCD-associated SNPs of SLC1A1 in an autism sample / Camille W. BRUNE in Autism Research, 1-2 (April 2008)  

Permalink

A pharmacogenetic study of escitalopram in autism spectrum disorders / Thomas OWLEY in Autism Research, 3-1 (February 2010)  

Permalink

Prenatal exposure to paternal smoking and likelihood for autism spectrum disorder / Bora KIM in Autism, 26-7 (October 2022)  

Permalink

Prevalence and cumulative incidence of autism spectrum disorders and the patterns of co-occurring neurodevelopmental disorders in a total population sample of 5-year-old children / Manabu SAITO in Molecular Autism, 11 (2020)  

Permalink

Research Review: 'Ain't misbehavin': Towards a developmentally-specified nosology for preschool disruptive behavior / Lauren S. WAKSCHLAG in Journal of Child Psychology and Psychiatry, 51-1 (January 2010)  

Permalink

Social attention to activities in children and adults with autism spectrum disorder: effects of context and age / Dzmitry A. KALIUKHOVICH in Molecular Autism, 11 (2020)  

Permalink

---

1 2 (1 - 15 / 16) Par page : Tout afficher